follow @HspNews
RSS Feeds
Find Us on Facebook

The Hospitalist News Blog

HHS Cries Foul on Insurance Hikes
January 12, 2012



Bookmark and Share

Nowhere in the thousands of pages of the Affordable Care Act does it give the federal government the power to stop insurance companies from charging excessive premiums. But the controversial health reform law does grant the Department of the Health and Human Services the right review some large rate increases and to tell consumers when they think health plans are charging too much.

HHS did just that today when it held a press conference to protest what it said were “unreasonable” rate hikes by Trustmark Life Insurance Company in five states. The company recently proposed premiums hikes of 13% or more for its plan members in Alabama, Arizona, Pennsylvania, Virginia, and Wyoming.

 

Courtesy Wikimedia Commons/FBI Buffalo Field Office/Public Domain

Gary Cohen, the Acting Director of Oversight at the HHS Center for Consumer Information and Insurance Oversight, said it wasn’t just that the increases were so high. HHS officials, after consulting with a team of outside analysts, concluded the rates were unreasonably high because the health insurance company was spending only a small percentage of its premium dollars on medical care and quality improvements. Trustmark also based its increases on “unreasonable assumptions,” HHS said. You can read more about HHS rate review authority here.

In its challenge to Trustmark, HHS called on the company to immediately rescind the rates, issue refunds to consumers, or publicly explain why they are standing by such a large rate hike.

It looks like Trustmark is going to stand by its rate increase. Following the HHS press conference, Trustmark issued its own statement saying that they disagreed with the federal government’s assumptions and conclusions. “Our premiums are driven by the rising cost and increased utilization of medical services,” the company wrote. “As a smaller carrier, our loss ratios can vary significantly from year to year, and we take that volatility into consideration.” As for spending too little of its premium dollars on medical care, the company said it has been in compliance with the federal Medical Loss Ratio requirements in that area. However, if they should fail to meet the federal standards, they will offer rebates to consumers.

So is this an effective strategy for bringing down health insurance rates? Share your thoughts on whether rate review by HHS and public disclosure will be powerful enough to force companies to keep premiums low or if you think insurers will be willing to ride out some bad press.

— Mary Ellen Schneider

I would like to receive Hospitalist News E-Newsletter each week.


Specialty Focus


  Cardiovascular Disease

  Diabetes, Endocrinology & Metabolism

  Gastroenterology

  Hematology/Thrombosis

  Imaging

  Infectious Diseases

  Nephrology

  Neurology & Pain

  Palliative/Hospice

  Pediatrics

  Perioperative Medicine

  Practice Trends

  Psychiatry

  Pulmonary Disease

  Trauma


calendar
May 11 - 21
Departs Civitavecchia,
Rheumatology and Orthopaedics
May 11 - 21
Departs Civitavecchia,
Rheumatology and Orthopaedics
May 12 - 21
Departs Oslo,
Pain Management/Neurology/Compliance
May 18 - 23
San Francisco, CA
American Thoracic Society (ATS): International Conference
May 19 - 22
New York, NY
American Society of Hypertension (ASH): Annual Scientific Meeting
May 19 - 22
San Diego, CA
Digestive Disease Week (DDW 2012)
May 19 - 22
Sao Paulo,
XXX RADLA 2012: Annual Meeting of Latin American Dermatologists
May 19 - 24
Atlanta, GA
American Urological Association (AUA): Annual Meeting
May 19 - 23
Stockholm,
European Calcified Tissue Society (ECTS): Annual Congress
May 20 - 23
Brisbane,
Australasian College of Dermatologists: Annual Scientific Meeting
More Calendar »